The global Androgen Antagonist market is projected to grow from US$ 7180 million in 2024 to US$ 9956.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.

Androgen Antagonist Market

Market Analysis and Insights: Global Androgen Antagonist Market

The US & Canada market for Androgen Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Androgen Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Androgen Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Androgen Antagonist include Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui and Bayer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Androgen Antagonist is widely used in various fields, such as Prostate Cancer, Benign Prostatic Hyperplasia, Polycystic Ovary Syndrome (POCS) and Others, etc. Prostate Cancer provides greatest supports to the Androgen Antagonist industry development. In 2023, global % revenue of Androgen Antagonist went into Prostate Cancer filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Androgen Antagonist market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Androgen Antagonist, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Androgen Antagonist, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Androgen Antagonist revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Androgen Antagonist market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Androgen Antagonist revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Androgen Antagonist Market Report

Report Metric	Details
Report Name	Androgen Antagonist Market
Accounted market size in 2024	US$ 7180 million
Forecasted market size in 2030	US$ 9956.5 million
CAGR	5.6
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Steroidal Androgen Antagonist Nonsteroidal Androgen Antagonist
Segment by Application	Prostate Cancer Benign Prostatic Hyperplasia Polycystic Ovary Syndrome (POCS) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui, Bayer, Schering-Plough, Hinova Pharma, Jiangsu Hengrui Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Androgen Antagonist in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Androgen Antagonist companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Androgen Antagonist revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Androgen Antagonist Market growing?

Ans: The Androgen Antagonist Market witnessing a CAGR of 5.6 during the forecast period 2024-2030.

What is the Androgen Antagonist Market size in 2030?

Ans: The Androgen Antagonist Market size in 2030 will be US$ 9956.5 million.

Who are the main players in the Androgen Antagonist Market report?

Ans: The main players in the Androgen Antagonist Market are Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui, Bayer, Schering-Plough, Hinova Pharma, Jiangsu Hengrui Pharmaceuticals

What are the Application segmentation covered in the Androgen Antagonist Market report?

Ans: The Applications covered in the Androgen Antagonist Market report are Prostate Cancer, Benign Prostatic Hyperplasia, Polycystic Ovary Syndrome (POCS), Others

What are the Type segmentation covered in the Androgen Antagonist Market report?

Ans: The Types covered in the Androgen Antagonist Market report are Steroidal Androgen Antagonist, Nonsteroidal Androgen Antagonist

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Androgen Antagonist Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Steroidal Androgen Antagonist

1.2.3 Nonsteroidal Androgen Antagonist

1.3 Market by Application

1.3.1 Global Androgen Antagonist Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Prostate Cancer

1.3.3 Benign Prostatic Hyperplasia

1.3.4 Polycystic Ovary Syndrome (POCS)

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Androgen Antagonist Market Perspective (2019-2030)

2.2 Global Androgen Antagonist Growth Trends by Region

2.2.1 Androgen Antagonist Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Androgen Antagonist Historic Market Size by Region (2019-2024)

2.2.3 Androgen Antagonist Forecasted Market Size by Region (2025-2030)

2.3 Androgen Antagonist Market Dynamics

2.3.1 Androgen Antagonist Industry Trends

2.3.2 Androgen Antagonist Market Drivers

2.3.3 Androgen Antagonist Market Challenges

2.3.4 Androgen Antagonist Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Androgen Antagonist by Players

3.1.1 Global Androgen Antagonist Revenue by Players (2019-2024)

3.1.2 Global Androgen Antagonist Revenue Market Share by Players (2019-2024)

3.2 Global Androgen Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Androgen Antagonist, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Androgen Antagonist Market Concentration Ratio

3.4.1 Global Androgen Antagonist Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Androgen Antagonist Revenue in 2023

3.5 Global Key Players of Androgen Antagonist Head office and Area Served

3.6 Global Key Players of Androgen Antagonist, Product and Application

3.7 Global Key Players of Androgen Antagonist, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Androgen Antagonist Breakdown Data by Type

4.1 Global Androgen Antagonist Historic Market Size by Type (2019-2024)

4.2 Global Androgen Antagonist Forecasted Market Size by Type (2025-2030)

5 Androgen Antagonist Breakdown Data by Application

5.1 Global Androgen Antagonist Historic Market Size by Application (2019-2024)

5.2 Global Androgen Antagonist Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Androgen Antagonist Market Size (2019-2030)

6.2 North America Androgen Antagonist Market Size by Type

6.2.1 North America Androgen Antagonist Market Size by Type (2019-2024)

6.2.2 North America Androgen Antagonist Market Size by Type (2025-2030)

6.2.3 North America Androgen Antagonist Market Share by Type (2019-2030)

6.3 North America Androgen Antagonist Market Size by Application

6.3.1 North America Androgen Antagonist Market Size by Application (2019-2024)

6.3.2 North America Androgen Antagonist Market Size by Application (2025-2030)

6.3.3 North America Androgen Antagonist Market Share by Application (2019-2030)

6.4 North America Androgen Antagonist Market Size by Country

6.4.1 North America Androgen Antagonist Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Androgen Antagonist Market Size by Country (2019-2024)

6.4.3 North America Androgen Antagonist Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Androgen Antagonist Market Size (2019-2030)

7.2 Europe Androgen Antagonist Market Size by Type

7.2.1 Europe Androgen Antagonist Market Size by Type (2019-2024)

7.2.2 Europe Androgen Antagonist Market Size by Type (2025-2030)

7.2.3 Europe Androgen Antagonist Market Share by Type (2019-2030)

7.3 Europe Androgen Antagonist Market Size by Application

7.3.1 Europe Androgen Antagonist Market Size by Application (2019-2024)

7.3.2 Europe Androgen Antagonist Market Size by Application (2025-2030)

7.3.3 Europe Androgen Antagonist Market Share by Application (2019-2030)

7.4 Europe Androgen Antagonist Market Size by Country

7.4.1 Europe Androgen Antagonist Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Androgen Antagonist Market Size by Country (2019-2024)

7.4.3 Europe Androgen Antagonist Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Androgen Antagonist Market Size (2019-2030)

8.2 China Androgen Antagonist Market Size by Type

8.2.1 China Androgen Antagonist Market Size by Type (2019-2024)

8.2.2 China Androgen Antagonist Market Size by Type (2025-2030)

8.2.3 China Androgen Antagonist Market Share by Type (2019-2030)

8.3 China Androgen Antagonist Market Size by Application

8.3.1 China Androgen Antagonist Market Size by Application (2019-2024)

8.3.2 China Androgen Antagonist Market Size by Application (2025-2030)

8.3.3 China Androgen Antagonist Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Androgen Antagonist Market Size (2019-2030)

9.2 Asia Androgen Antagonist Market Size by Type

9.2.1 Asia Androgen Antagonist Market Size by Type (2019-2024)

9.2.2 Asia Androgen Antagonist Market Size by Type (2025-2030)

9.2.3 Asia Androgen Antagonist Market Share by Type (2019-2030)

9.3 Asia Androgen Antagonist Market Size by Application

9.3.1 Asia Androgen Antagonist Market Size by Application (2019-2024)

9.3.2 Asia Androgen Antagonist Market Size by Application (2025-2030)

9.3.3 Asia Androgen Antagonist Market Share by Application (2019-2030)

9.4 Asia Androgen Antagonist Market Size by Region

9.4.1 Asia Androgen Antagonist Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Androgen Antagonist Market Size by Region (2019-2024)

9.4.3 Asia Androgen Antagonist Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Androgen Antagonist Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Type

10.2.1 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Androgen Antagonist Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Application

10.3.1 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Androgen Antagonist Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country

10.4.1 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Androgen Antagonist Introduction

11.1.4 Pfizer Revenue in Androgen Antagonist Business (2019-2024)

11.1.5 Pfizer Recent Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Androgen Antagonist Introduction

11.2.4 Johnson & Johnson Revenue in Androgen Antagonist Business (2019-2024)

11.2.5 Johnson & Johnson Recent Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Androgen Antagonist Introduction

11.3.4 AstraZeneca Revenue in Androgen Antagonist Business (2019-2024)

11.3.5 AstraZeneca Recent Developments

11.4 Astellas

11.4.1 Astellas Company Details

11.4.2 Astellas Business Overview

11.4.3 Astellas Androgen Antagonist Introduction

11.4.4 Astellas Revenue in Androgen Antagonist Business (2019-2024)

11.4.5 Astellas Recent Developments

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Androgen Antagonist Introduction

11.5.4 Merck Revenue in Androgen Antagonist Business (2019-2024)

11.5.5 Merck Recent Developments

11.6 Sanofi

11.6.1 Sanofi Company Details

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Androgen Antagonist Introduction

11.6.4 Sanofi Revenue in Androgen Antagonist Business (2019-2024)

11.6.5 Sanofi Recent Developments

11.7 Orion Corporation

11.7.1 Orion Corporation Company Details

11.7.2 Orion Corporation Business Overview

11.7.3 Orion Corporation Androgen Antagonist Introduction

11.7.4 Orion Corporation Revenue in Androgen Antagonist Business (2019-2024)

11.7.5 Orion Corporation Recent Developments

11.8 Hengrui

11.8.1 Hengrui Company Details

11.8.2 Hengrui Business Overview

11.8.3 Hengrui Androgen Antagonist Introduction

11.8.4 Hengrui Revenue in Androgen Antagonist Business (2019-2024)

11.8.5 Hengrui Recent Developments

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Bayer Business Overview

11.9.3 Bayer Androgen Antagonist Introduction

11.9.4 Bayer Revenue in Androgen Antagonist Business (2019-2024)

11.9.5 Bayer Recent Developments

11.10 Schering-Plough

11.10.1 Schering-Plough Company Details

11.10.2 Schering-Plough Business Overview

11.10.3 Schering-Plough Androgen Antagonist Introduction

11.10.4 Schering-Plough Revenue in Androgen Antagonist Business (2019-2024)

11.10.5 Schering-Plough Recent Developments

11.11 Hinova Pharma

11.11.1 Hinova Pharma Company Details

11.11.2 Hinova Pharma Business Overview

11.11.3 Hinova Pharma Androgen Antagonist Introduction

11.11.4 Hinova Pharma Revenue in Androgen Antagonist Business (2019-2024)

11.11.5 Hinova Pharma Recent Developments

11.12 Jiangsu Hengrui Pharmaceuticals

11.12.1 Jiangsu Hengrui Pharmaceuticals Company Details

11.12.2 Jiangsu Hengrui Pharmaceuticals Business Overview

11.12.3 Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Introduction

11.12.4 Jiangsu Hengrui Pharmaceuticals Revenue in Androgen Antagonist Business (2019-2024)

11.12.5 Jiangsu Hengrui Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Jiangsu Hengrui Pharmaceuticals

Astellas

List of Tables

Table 1. Global Androgen Antagonist Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Steroidal Androgen Antagonist

Table 3. Key Players of Nonsteroidal Androgen Antagonist

Table 4. Global Androgen Antagonist Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Androgen Antagonist Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Androgen Antagonist Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Androgen Antagonist Market Share by Region (2019-2024)

Table 8. Global Androgen Antagonist Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Androgen Antagonist Market Share by Region (2025-2030)

Table 10. Androgen Antagonist Market Trends

Table 11. Androgen Antagonist Market Drivers

Table 12. Androgen Antagonist Market Challenges

Table 13. Androgen Antagonist Market Restraints

Table 14. Global Androgen Antagonist Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Androgen Antagonist Revenue Share by Players (2019-2024)

Table 16. Global Top Androgen Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Antagonist as of 2023)

Table 17. Global Androgen Antagonist Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Androgen Antagonist Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Androgen Antagonist, Headquarters and Area Served

Table 20. Global Key Players of Androgen Antagonist, Product and Application

Table 21. Global Key Players of Androgen Antagonist, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Androgen Antagonist Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Androgen Antagonist Revenue Market Share by Type (2019-2024)

Table 25. Global Androgen Antagonist Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Androgen Antagonist Revenue Market Share by Type (2025-2030)

Table 27. Global Androgen Antagonist Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Androgen Antagonist Revenue Share by Application (2019-2024)

Table 29. Global Androgen Antagonist Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Androgen Antagonist Revenue Share by Application (2025-2030)

Table 31. North America Androgen Antagonist Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Androgen Antagonist Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Androgen Antagonist Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Androgen Antagonist Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Androgen Antagonist Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Androgen Antagonist Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Androgen Antagonist Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Androgen Antagonist Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Androgen Antagonist Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Androgen Antagonist Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Androgen Antagonist Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Androgen Antagonist Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Androgen Antagonist Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Androgen Antagonist Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Androgen Antagonist Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Androgen Antagonist Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Androgen Antagonist Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Androgen Antagonist Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Androgen Antagonist Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Androgen Antagonist Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Androgen Antagonist Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Androgen Antagonist Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Androgen Antagonist Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Androgen Antagonist Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Androgen Antagonist Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Androgen Antagonist Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country (2025-2030) & (US$ Million)

Table 63. Pfizer Company Details

Table 64. Pfizer Business Overview

Table 65. Pfizer Androgen Antagonist Product

Table 66. Pfizer Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 67. Pfizer Recent Developments

Table 68. Johnson & Johnson Company Details

Table 69. Johnson & Johnson Business Overview

Table 70. Johnson & Johnson Androgen Antagonist Product

Table 71. Johnson & Johnson Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 72. Johnson & Johnson Recent Developments

Table 73. AstraZeneca Company Details

Table 74. AstraZeneca Business Overview

Table 75. AstraZeneca Androgen Antagonist Product

Table 76. AstraZeneca Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 77. AstraZeneca Recent Developments

Table 78. Astellas Company Details

Table 79. Astellas Business Overview

Table 80. Astellas Androgen Antagonist Product

Table 81. Astellas Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 82. Astellas Recent Developments

Table 83. Merck Company Details

Table 84. Merck Business Overview

Table 85. Merck Androgen Antagonist Product

Table 86. Merck Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 87. Merck Recent Developments

Table 88. Sanofi Company Details

Table 89. Sanofi Business Overview

Table 90. Sanofi Androgen Antagonist Product

Table 91. Sanofi Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 92. Sanofi Recent Developments

Table 93. Orion Corporation Company Details

Table 94. Orion Corporation Business Overview

Table 95. Orion Corporation Androgen Antagonist Product

Table 96. Orion Corporation Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 97. Orion Corporation Recent Developments

Table 98. Hengrui Company Details

Table 99. Hengrui Business Overview

Table 100. Hengrui Androgen Antagonist Product

Table 101. Hengrui Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 102. Hengrui Recent Developments

Table 103. Bayer Company Details

Table 104. Bayer Business Overview

Table 105. Bayer Androgen Antagonist Product

Table 106. Bayer Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 107. Bayer Recent Developments

Table 108. Schering-Plough Company Details

Table 109. Schering-Plough Business Overview

Table 110. Schering-Plough Androgen Antagonist Product

Table 111. Schering-Plough Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 112. Schering-Plough Recent Developments

Table 113. Hinova Pharma Company Details

Table 114. Hinova Pharma Business Overview

Table 115. Hinova Pharma Androgen Antagonist Product

Table 116. Hinova Pharma Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 117. Hinova Pharma Recent Developments

Table 118. Jiangsu Hengrui Pharmaceuticals Company Details

Table 119. Jiangsu Hengrui Pharmaceuticals Business Overview

Table 120. Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Product

Table 121. Jiangsu Hengrui Pharmaceuticals Revenue in Androgen Antagonist Business (2019-2024) & (US$ Million)

Table 122. Jiangsu Hengrui Pharmaceuticals Recent Developments

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Androgen Antagonist Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Androgen Antagonist Market Share by Type: 2023 VS 2030

Figure 3. Steroidal Androgen Antagonist Features

Figure 4. Nonsteroidal Androgen Antagonist Features

Figure 5. Global Androgen Antagonist Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Androgen Antagonist Market Share by Application: 2023 VS 2030

Figure 7. Prostate Cancer Case Studies

Figure 8. Benign Prostatic Hyperplasia Case Studies

Figure 9. Polycystic Ovary Syndrome (POCS) Case Studies

Figure 10. Others Case Studies

Figure 11. Androgen Antagonist Report Years Considered

Figure 12. Global Androgen Antagonist Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Androgen Antagonist Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Androgen Antagonist Market Share by Region: 2023 VS 2030

Figure 15. Global Androgen Antagonist Market Share by Players in 2023

Figure 16. Global Top Androgen Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Antagonist as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Androgen Antagonist Revenue in 2023

Figure 18. North America Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Androgen Antagonist Market Share by Type (2019-2030)

Figure 20. North America Androgen Antagonist Market Share by Application (2019-2030)

Figure 21. North America Androgen Antagonist Market Share by Country (2019-2030)

Figure 22. United States Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Androgen Antagonist Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Androgen Antagonist Market Share by Type (2019-2030)

Figure 26. Europe Androgen Antagonist Market Share by Application (2019-2030)

Figure 27. Europe Androgen Antagonist Market Share by Country (2019-2030)

Figure 28. Germany Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Androgen Antagonist Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Androgen Antagonist Market Share by Type (2019-2030)

Figure 36. China Androgen Antagonist Market Share by Application (2019-2030)

Figure 37. Asia Androgen Antagonist Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Androgen Antagonist Market Share by Type (2019-2030)

Figure 39. Asia Androgen Antagonist Market Share by Application (2019-2030)

Figure 40. Asia Androgen Antagonist Market Share by Region (2019-2030)

Figure 41. Japan Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Androgen Antagonist Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Androgen Antagonist Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Androgen Antagonist Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Androgen Antagonist Market Share by Country (2019-2030)

Figure 51. Brazil Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Androgen Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Pfizer Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 58. Johnson & Johnson Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 59. AstraZeneca Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 60. Astellas Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 61. Merck Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 62. Sanofi Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 63. Orion Corporation Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 64. Hengrui Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 65. Bayer Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 66. Schering-Plough Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 67. Hinova Pharma Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 68. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Androgen Antagonist Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Molecular Quality Controls Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-4P1358

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Ozone Therapy in Dermatology Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-1O14324

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Ankle Replacement System Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-36H5857

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pharyngeal Cancer Therapeutics Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-9E14435

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions